As of 2025-05-23, the Intrinsic Value of China Tian Yuan Healthcare Group Ltd (557.HK) is (2.51) HKD. This 557.HK valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.80 HKD, the upside of China Tian Yuan Healthcare Group Ltd is -413.40%.
The range of the Intrinsic Value is (12.79) - (1.46) HKD
Based on its market price of 0.80 HKD and our intrinsic valuation, China Tian Yuan Healthcare Group Ltd (557.HK) is overvalued by 413.40%.
Note: result may not be accurate due to the invalid valuation result of DCF model.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (12.79) - (1.46) | (2.51) | -413.4% |
| DCF (Growth 10y) | (1.45) - (11.33) | (2.37) | -396.2% |
| DCF (EBITDA 5y) | (0.55) - (0.71) | (1,234.50) | -123450.0% |
| DCF (EBITDA 10y) | (0.78) - (1.00) | (1,234.50) | -123450.0% |
| Fair Value | -0.43 - -0.43 | -0.43 | -153.63% |
| P/E | (0.40) - (0.39) | (0.41) | -151.0% |
| EV/EBITDA | (0.11) - (0.15) | (0.14) | -117.0% |
| EPV | (0.18) - (0.26) | (0.22) | -127.6% |
| DDM - Stable | (1.60) - (19.78) | (10.69) | -1436.1% |
| DDM - Multi | (2.02) - (19.28) | (3.65) | -556.4% |
| Market Cap (mil) | 319.18 |
| Beta | -0.73 |
| Outstanding shares (mil) | 398.98 |
| Enterprise Value (mil) | 340.70 |
| Market risk premium | 5.98% |
| Cost of Equity | 6.07% |
| Cost of Debt | 15.48% |
| WACC | 7.21% |